Enliven Therapeutics Inc. (ELVN)
Enliven Therapeutics Max Pain By Strike
ELVN trades at $20.85, 19.1% above the near-term max pain of $17.5 expiring Sep 19, 2025 (25 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is falling across expirations ($2.5-$95), signaling increased put positioning or downside protection. High dispersion in max pain levels suggests competing forces and potential volatility.
Enliven Therapeutics Max Pain By Expiry
Max pain for ELVN shows a downward trend from 95 to 2.5, indicating bearish sentiment or hedging activity. The 356% spread signals divergent expectations across timeframes. Most levels below 20.85 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Sep 19, 2025 | 17.5 | -3.35 (-16.07%) |
| Oct 17, 2025 | 2.5 | -18.35 (-88.01%) |
| Dec 19, 2025 | 10 | -10.85 (-52.04%) |
| Jan 16, 2026 | 95 | 74.15 (355.64%) |
| Mar 20, 2026 | 5 | -15.85 (-76.02%) |